
2seventy bio A Buy For Abecma And CAR T Platform (NASDAQ:TSVT)
selvanegra/iStock via Getty Images 2seventy bio (NASDAQ:TSVT) is now a commercial-stage pharmaceutical company, as its cancer therapy Abecma is marketed by Bristol Myers Squibb (BMY). So far, however, revenue to 2seventy itself has been slow […]